Swiss drugmaker Roche on Friday won a key European panel’s recommendation for its multiple sclerosis drug Ocrevus, which is on...
Read moreRecipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in...
Read moreINC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is...
Read moreServier Germany will start to co-promote Novartis’ potential blockbuster Entresto® (Sacubitril/Valsartan) used in cardiovascular diseases in Germany from November 1st...
Read moreBoehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their strategic partnership to bring innovative treatments to cancer...
Read moreTakeda Pharmaceutical Company Limited announced the presentation of real-world evidence from two analyses evaluating the safety profile of Entyvio® (vedolizumab),...
Read moreAstellas announced the five C3 Prize finalists chosen from more than 160 entries to present their ideas to change cancer...
Read moreBiogen (NASDAQ: BIIB) and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best Biotechnology Product for...
Read moreRoche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in...
Read moreMylan N.V. announced that the United Kingdom's High Court of Justice has issued a decision in favor of Mylan and...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.